Maple Capital Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $221K | Sell |
544
-17
| -3% | -$6.89K | 0.02% | 109 |
|
|
2025
Q1 | $279K | Sell |
561
-53
| -9% | -$26.4K | 0.02% | 99 |
|
|
2024
Q4 | $319K | Sell |
614
-32
| -5% | -$16.6K | 0.02% | 93 |
|
|
2024
Q3 | $400K | Sell |
646
-39
| -6% | -$24.1K | 0.03% | 81 |
|
|
2024
Q2 | $379K | Buy |
685
+5
| +0.7% | +$2.77K | 0.03% | 87 |
|
|
2024
Q1 | $395K | Buy |
+680
| New | +$395K | 0.04% | 78 |
|
|
2022
Q1 | – | Sell |
-301
| Closed | -$201K | – | 111 |
|
|
2021
Q4 | $201K | Sell |
301
-225
| -43% | -$150K | 0.02% | 105 |
|
|
2021
Q3 | $301K | Hold |
526
| – | – | 0.04% | 84 |
|
|
2021
Q2 | $286K | Buy |
526
+17
| +3% | +$9.24K | 0.03% | 88 |
|
|
2021
Q1 | $232K | Buy |
509
+18
| +4% | +$8.2K | 0.03% | 89 |
|
|
2020
Q4 | $229K | Sell |
491
-4
| -0.8% | -$1.87K | 0.04% | 90 |
|
|
2020
Q3 | $242K | Sell |
495
-176
| -26% | -$86K | 0.04% | 93 |
|
|
2020
Q2 | $243K | Sell |
671
-644
| -49% | -$233K | 0.05% | 90 |
|
|
2020
Q1 | $373K | Sell |
1,315
-339
| -20% | -$96.2K | 0.09% | 71 |
|
|
2019
Q4 | $537K | Hold |
1,654
| – | – | 0.1% | 78 |
|
|
2019
Q3 | $482K | Sell |
1,654
-162
| -9% | -$47.2K | 0.1% | 77 |
|
|
2019
Q2 | $533K | Sell |
1,816
-678
| -27% | -$199K | 0.12% | 74 |
|
|
2019
Q1 | $683K | Sell |
2,494
-180
| -7% | -$49.3K | 0.16% | 62 |
|
|
2018
Q4 | $598K | Sell |
2,674
-25
| -0.9% | -$5.59K | 0.15% | 70 |
|
|
2018
Q3 | $659K | Sell |
2,699
-405
| -13% | -$98.9K | 0.15% | 73 |
|
|
2018
Q2 | $643K | Sell |
3,104
-800
| -20% | -$166K | 0.16% | 70 |
|
|
2018
Q1 | $806K | Buy |
3,904
+675
| +21% | +$139K | 0.2% | 69 |
|
|
2017
Q4 | $613K | Buy |
3,229
+450
| +16% | +$85.4K | 0.16% | 77 |
|
|
2017
Q3 | $526K | Buy |
2,779
+504
| +22% | +$95.4K | 0.14% | 78 |
|
|
2017
Q2 | $397K | Buy |
2,275
+138
| +6% | +$24.1K | 0.11% | 94 |
|
|
2017
Q1 | $328K | Buy |
2,137
+453
| +27% | +$69.5K | 0.1% | 109 |
|
|
2016
Q4 | $238K | Buy |
1,684
+290
| +21% | +$41K | 0.07% | 117 |
|
|
2016
Q3 | $222K | Buy |
+1,394
| New | +$222K | 0.07% | 118 |
|